The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis
- PMID: 33082885
- PMCID: PMC7556081
- DOI: 10.1155/2020/8830471
The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis
Abstract
Background: Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease worldwide. Although there have been many investigations on biomarkers for DN, there is no consistent conclusion about reliable biomarkers. The purpose of this study was to perform a systematic review and meta-analysis of the role of circulating retinol-binding protein 4 (RBP4) in the type 2 diabetes mellitus (T2DM) patients with kidney diseases.
Materials and methods: We searched the PubMed, MEDLINE, EMBASE, and Web of Science databases for publications. For the 12 cross-sectional studies that we included in the review, we calculated standard mean differences (SMD) with 95% confidence intervals (CI) for continuous data when the applied scales were different. Risk of bias of included trials was assessed by using the Newcastle-Ottawa Scale.
Results: RBP4 concentrations in the micro-, macro-, or micro+macroalbuminuria groups were significantly higher than those in the normal albuminuria group of T2DM patients [P = 0.001, SMD 1.07, 95% CI (0.41, 1.73)]. The estimated glomerular filtration rate (eGFR) was negatively associated with circulating RBP4 concentrations in patients with T2DM [summary Fisher's Z = -0.48, 95% CI (-0.69, -0.26), P < 0.0001]. The albumin-to-creatinine ratio (ACR) was positively associated with circulating RBP4 concentrations in patients with T2DM [summary Fisher's Z = 0.20, 95% CI (0.08, 0.32), P = 0.001].
Conclusion: The levels of circulating RBP4 were significantly higher both in T2DM subjects with micro/macroalbuminuria and in T2DM subjects with declined eGFR. The levels of circulating RBP4 were positively correlated with ACR but negatively correlated with eGFR. Circulating RBP4 could be a reliable biomarker for kidney diseases in T2DM.
Copyright © 2020 Li Zhang et al.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this paper.
Figures






Similar articles
-
Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes.J Endocrinol Invest. 2010 Nov;33(10):725-9. doi: 10.1007/BF03346678. Epub 2010 Apr 30. J Endocrinol Invest. 2010. PMID: 20436266
-
Diagnostic value of retinol-binding protein 4 in diabetic nephropathy: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 Apr 22;15:1356131. doi: 10.3389/fendo.2024.1356131. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38711978 Free PMC article.
-
Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.Diabetes Metab Res Rev. 2008 Nov-Dec;24(8):629-34. doi: 10.1002/dmrr.894. Diabetes Metab Res Rev. 2008. PMID: 18973209
-
Elevated serum retinol-binding protein 4 concentrations are associated with chronic kidney disease but not with the higher carotid intima-media thickness in type 2 diabetic subjects.Endocr J. 2011;58(10):841-7. doi: 10.1507/endocrj.ej11-0028. Epub 2011 Aug 4. Endocr J. 2011. PMID: 21817822
-
Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis.Front Public Health. 2024 Mar 12;12:1348970. doi: 10.3389/fpubh.2024.1348970. eCollection 2024. Front Public Health. 2024. PMID: 38532976 Free PMC article.
Cited by
-
Shift work is associated with an increased risk of type 2 diabetes and elevated RBP4 level: cross sectional analysis from the OHSPIW cohort study.BMC Public Health. 2023 Jun 14;23(1):1139. doi: 10.1186/s12889-023-16091-y. BMC Public Health. 2023. PMID: 37312059 Free PMC article.
-
Treatment Effect of Type 2 Diabetes Patients in Outpatient Department Based on Blockchain Electronic Mobile Medical App.J Healthc Eng. 2021 Mar 1;2021:6693810. doi: 10.1155/2021/6693810. eCollection 2021. J Healthc Eng. 2021. Retraction in: J Healthc Eng. 2023 Jun 21;2023:9858173. doi: 10.1155/2023/9858173. PMID: 33728034 Free PMC article. Retracted.
-
LncRNA PTGS2 regulates islet β-cell function through the miR-146a-5p/RBP4 axis and its diagnostic value in type 2 diabetes mellitus.Am J Transl Res. 2021 Oct 15;13(10):11316-11328. eCollection 2021. Am J Transl Res. 2021. PMID: 34786060 Free PMC article.
-
Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).Mol Med Rep. 2022 Jul;26(1):244. doi: 10.3892/mmr.2022.12760. Epub 2022 Jun 3. Mol Med Rep. 2022. PMID: 35656886 Free PMC article. Review.
-
Correlation and Diagnostic Value of Serum Cys-C, RBP4, and NGAL with the Condition of Patients with Traumatic Acute Kidney Injury.Evid Based Complement Alternat Med. 2021 Sep 3;2021:4990941. doi: 10.1155/2021/4990941. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 13;2023:9846371. doi: 10.1155/2023/9846371. PMID: 34518769 Free PMC article. Retracted.
References
-
- Vijay S., Hamide A., Senthilkumar G. P., Mehalingam V. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2018;12(5):649–652. doi: 10.1016/j.dsx.2018.04.017. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous